Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 6,889 |
|
|||||
| News | - | ||||||
| Day High | 5.44 | Low High |
|||||
| Day Low | 4.73 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Pluri Inc | PLUR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.457 | 9.33% | 5.357 | 23:00:01 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.82 | 4.73 | 5.44 | 5.357 | 4.90 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 389 | 6,889 | US$ 5.21 | US$ 35,907 | - | 3.4488 - 8.56 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:22:47 | 1 | US$ 5.52 | USD |
Pluri Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 222.33M | 41.48M | - | 287k | -28.32M | -0.68 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Pluri News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PLUR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.00 | 5.51 | 4.73 | 5.11 | 11,450 | 0.357 | 7.14% |
| 1 Month | 5.70 | 6.26 | 4.50 | 5.57 | 57,810 | -0.343 | -6.02% |
| 3 Months | 5.76 | 8.48 | 4.50 | 6.70 | 87,842 | -0.403 | -7.00% |
| 6 Months | 3.7952 | 8.48 | 3.4488 | 5.72 | 91,652 | 1.56 | 41.15% |
| 1 Year | 7.92 | 8.56 | 3.4488 | 5.77 | 77,426 | -2.56 | -32.36% |
| 3 Years | 8.00 | 11.5784 | 3.4488 | 6.48 | 73,780 | -2.64 | -33.04% |
| 5 Years | 8.00 | 11.5784 | 3.4488 | 6.48 | 73,780 | -2.64 | -33.04% |
Pluri Description
| Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pluristem Therapeutics Inc. Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. |
